Showing results (61-70 of 94) with videos related to

Sort By:
Pageof 10
Bone Marrow Transplantation|November 24, 2020
Anti-CD19 CAR-T therapy for EBV-negative posttransplantation lymphoproliferative disease-a single center case seriesEfrat Luttwak, David Hagin, Chava Perry, et al.
Frontiers in Immunology|March 27, 2026
Low serum IgE is associated with an increased risk of chronic lymphocytic leukemia: a large retrospective cohort studyRamon Cohen, Daniel Elbirt, Shay Nemet, et al.
Journal of Clinical Apheresis|July 13, 2023
Extracorporeal photopheresis induces NETosis in neutrophils derived from patients with chronic graft-vs-host diseaseIdan Goldberg, Galit Granot, Alona Telerman, et al.
Blood Advances|August 14, 2020
Efficacy of folinic acid rescue following MTX GVHD prophylaxis: results of a double-blind, randomized, controlled studyMoshe Yeshurun, Uri Rozovski, Oren Pasvolsky, et al.
Leukemia & Lymphoma|May 20, 2021
Eltrombopag for enhancement of platelet engraftment in patients undergoing allogeneic cord blood transplantationOren Pasvolsky, Liat Shargian, Uri Rozovski, et al.
International Journal of Molecular Sciences|January 8, 2025
Interferon-α Inhibits NET Formation in Neutrophils Derived from Patients with Myeloproliferative Neoplasms in a Neutrophil Sub-Population-Specific MannerShirly Partouche, Idan Goldberg, Erez Halperin, et al.
Annals of Hematology|January 28, 2022
Evaluating outcomes of adult patients with acute lymphoblastic leukemia and lymphoblastic lymphoma treated on the GMALL 07/2003 protocolDanielle Fredman, Yakir Moshe, Ofir Wolach, et al.
Annals of Hematology|September 13, 2019
Midostaurin in combination with intensive chemotherapy is safe and associated with improved remission rates and higher transplantation rates in first remission-a multi-center historical control studyTamar Berger, Uri Rozovski, Yakir Moshe, et al.
Annals of Hematology|June 22, 2022
Venetoclax in combination with FLAG-IDA-based protocol for patients with acute myeloid leukemia: a real-world analysisOfir Wolach, Avraham Frisch, Liat Shargian, et al.
Leukemia & Lymphoma|April 21, 2021
Post-transplantation maintenance with sorafenib or midostaurin for FLT3 positive AML patients - a multicenter retrospective observational studyShai Shimony, Moshe Yeshurun, Ofir Wolach, et al.
Pageof 10